Cheapest S&P 500 Stocks Ranked: 30 Best Value Buys

An analysis identified 30 attractively valued large-cap S&P 500 stocks, including names like Adobe, Altria, and Amgen, challenging the perception of an universally expensive market. These "best value buys" were ranked using the Magic Formula system based on key financial metrics, highlighting specific sector opportunities for investors seeking quality at a reasonable price.

Analysis

The analysis presents a curated list of 30 large-cap S&P 500 stocks, including Adobe (ADBE), Altria (MO), and Amgen (AMGN), identified as attractively valued based on the 'Magic Formula' screening system. This challenges the perception of a universally expensive market by highlighting specific pockets of value among companies with market capitalizations of $16 billion or greater. The article's thesis carries a 'strongly positive' sentiment (score: 0.75), reflecting optimism about these select opportunities. However, its market impact is considered moderate (score: 0.45), indicating it is an opinion piece rather than definitive institutional research. It is also pertinent to note the author's disclosure of long positions in several securities, including Amgen (AMGN), Qualcomm (QCOM), and various broad market ETFs, which provides context on their positioning but also suggests a potential for confirmation bias.

Key Decisions for Investors

• Investors seeking value within the U.S. large-cap space could use the identified list of 30 stocks as a starting point for further due diligence, focusing on the fundamental merits of names like Adobe and Altria.
• It is crucial to independently verify the quantitative metrics and qualitative thesis for any stock mentioned, as the analysis originates from a non-institutional author and is explicitly not provided as licensed financial advice.
• Consider the author's disclosed long position in Amgen (AMGN) as a point of potential bias; the investment case for each stock should be scrutinized independently of the author's own holdings.
• The findings support the viability of a factor-based strategy targeting quality and value, suggesting that targeted stock selection may still yield opportunities even if broad market indexes appear overextended.